Lantheus Holdings, Inc. Logo

Lantheus Holdings, Inc. (1LNTH)

MTA

Currency in EUR
87.10
0.00 (0.00%)

Real-time Data

07:00 AM

Day's Range

87.10
87.10

52 wk Range

42.02
107.20

Overview - 1LNTH - Lantheus Holdings, Inc.

Key Statistics

Valuation

Enterprise Value

4.82B

P/E (Trailing)

‪24.44‬

Price / Sales (TTM)

‪3.66‬

Price / Book

‪5.08‬

EV / EBITDA

‪14.35‬

Profitability

Gross Margin

‪62.30%‬

Profit Margin

‪17.69%‬

Operating Margin

‪25.81%‬

Return on Assets

‪8.37%‬

Return on Equity

‪22.21%‬

Ownership

Shares Outstanding

65.26M

Float

58.49M

Held by Insiders

‪2.07%‬

Held by Institutions

‪117.16%‬

Price stats

Beta

‪-0.03‬

50-Day Avg

‪89.61‬

200-Day Avg

‪70.34‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 1LNTH - Lantheus Holdings, Inc.

Peers - 1LNTH - Lantheus Holdings, Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.

Profile Summary - 1LNTH - Lantheus Holdings, Inc.

About

Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company that develops, manufactures, and commercializes diagnostic and therapeutic products to assist clinicians in diagnosing and treating heart disease, cancer, and other conditions worldwide. Its portfolio includes DEFINITY, an injectable ultrasound…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1.19K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.